PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011
Target Area: All 32 current ART sites and their 138 satellite clinics and future ART roll out sites in Botswana
Implementing Partners: Implementing Partners: Masa The National ARV Therapy Program, Ministry of Health (MoH), Botswana; Botswana-Harvard AIDS Institute (BHP); and Harvard School of Public Health (HSPH)
Statement of Needs: Started in 2002, the Masa Program is currently supporting more than 107,000(Aug 09) ART patients at 32 ART sites and their 109(Aug 09) currently 138 satellite clinics countrywide. Constraints that will continue to impede the Botswana Government's plans to provide treatment and care to an estimated 125,000 patients in 600 ART treatment sites by 2013are: shortage, turnover, and attrition of qualified health professionals; lack of coordination among HIV/AIDS-related programs, limited capacity to conduct timely CD4 and viral load testing; and an inadequate system of tracking and monitoring ART patients.
Major Goals and Targets Planned: The goal of the project is to support the Masa program and its current 32 sites and their 138 satellite clinics and future ART sites by: 1) developing a sustainable capacity in clinical care and treatment of HIV/AIDS patients through training, on-site support, and roll out of facilities; 2) developing a sustainable capacity in CD4, viral load, and other lab testing, and supporting countrywide decentralization of laboratories; 3) establishing a Monitoring and Evaluation Unit to track ART patients and monitor the progress and effectiveness of the Masa program; and 4) implementing and operationalizing a fully functional Botswana-based NGO, BHP, whose governance is shared between the Botswana Ministry of Health and Harvard to ensure PEPFAR sustainability.
Project Accomplishments: In Year 06, the Clinical Master Trainers' pharmacists, physicians and nurse/midwives conducted needs and pharmacy assessments, training in ART care & treatment, Nurse Dispensing and Prescribing, on-site and/or telephone support at 29 ART sites and 95(Sept 09) satellite clinics, set up treatment failure management registries and pilot of Universal HAARTin 4 sites (incl hospital, supporting clinics and feeder health posts). QAI activities continued to be integrated into site support. The Laboratory Master Trainers collaborated on production of a laboratory training manual and provided training and follow-up support for 23 laboratories in CD4 and 10 laboratories in viral load testing. Decentralized labs performed 55% and 29% CD4 and viral load tests respectively countrywide this year. The M&E Unit of Masa provided consolidated monthly reports, conducted data training and data audits, upgraded, piloted, and rolled out a SQL-server-based electronic application (PIMS II), and provided a dataset?? QOL BHP was operationalized as a Limited Liability Corporation (LLC) in Botswana on September 1. 2009. BHP applied for and was awarded two PEPFAR Cooperative Agreements as well as other USG and non-USG awards.
Overview of Continuation Activities: In Year 07, the Clinical Master Trainers will continue to roll out facilities; provide training and support in HIV/AIDS treatment and care to all ART sites and their satellite clinics with specific training and support for nurse prescribing and dispensing, QAI, and pediatric scale-up; continue to develop training materials; and collaborate to integrate PMTCT, TB and other HIV/AIDS-related activities. The Laboratory Master Trainers will continue to provide training and support in, CD4 and viral load testing at the decentralized labs; provide new training in hematology, chemistry, microbiology, lab data management, reagent logistics, and QAI; and provide Rapid HIV and Dry Blood Spot testing training for lay counselors. The M&E Unit will complete deployment and training on PIMS II, to ARV sites; refine and expand indicators & management tools, especially for PMTCT; integrate functions of the national system, and establish IT support to the department. BHP as an LLC will be fully operationalized.
Future Goals and Targets: By the end of Yr 7, all established ART sites will have received training and support through the Clinical Master Trainer, Lab Master Trainer, and Monitoring and Evaluation Unit programs. The M&E Unit will have developed systems to monitor the national ART program and provided reports and analyses to inform the Government of Botswana in HIV/AIDS care and treatment policies. All activities of the Harvard Botswana PEPFAR grant will have been fully transitioned to the BHP LLC. and will continue to apply for future funding to support and sustain HIV prevention, care and treatment programs in Botswana in the years to come.
10.T.AT07: Harvard Botswana AIDS Initiative partnership - 2,786,962.00
The Clinical Master Trainer program will expand its activities in the following areas in conjunction with:
-The Prevention of Mother to Child Transmission (PMTCT) Program to include the PMTCT pilot project for universal highly active anti-retroviral therapy (HAART) with the PMTCT program and training on dried blood spots (DBS) and Routine HIV Testing (RHT) for the expanded nursing role in testing.
-The Botswana National TB Program (BNTP), which will include TB/HIV co-infection, Isoniazid Preventative Therapy (IPT) integration activities in anti-retroviral (ARV) roll out clinics, and the development of TB/HIV adherence materials to be incorporated into the training and mentoring activities.
-Masa, the anti-retroviral (ARV) distribution program, will incorporate expanded pediatric expert training for identifying infected children, the Nurse Training Initiative for prescribing and dispensing, and training in conjunction with the Palliative Care Unit on the training package for community volunteers.
-The Ministry of Local Government (MLG) will add the nurse dispensing training.
-The Laboratory Master Trainers program will expand its activities to include the development of training manuals and training in chemistry, hematology and tuberculosis microscopy in the ARV clinic laboratories and standardization, standard operating procedures (SOP), and an external quality assurance (EQA) program for new ARV clinic laboratories.
The Track I funding mechanism will end by 2012. In this regard and in line with the PEPFAR requirements, a local organization will be put in place to implement Harvard's activities in Botswana. The Harvard School of Public Health will embark on strengthening the capacity of the Botswana Harvard Partnership LLC, a local organization to implement the Master Trainer program in Botswana, which has in place a transition plan to achieve this.
The transition plan consists of:
1. Harvard will ensure that the local entity fulfills the PEPFAR definition of a local organization.
2. An amount TBD will be subgranted to BHP LLC in FY10 to assist the organization in setting up and picking up activities of the Master Trainers Health Care Provider Training.
3. BHP LLC will then progressively take over activities related to the project and in the future, apply for PEPFAR or any other award relevant to the program. BHP LLC will be able to subgrant to Harvard in the case of the need for any consultancies or other technical assistance required.
